Description
Description
Tablets are flat-shaped, with a bevel and chamfer, from white to almost white. MATERIA MEDICA is inscribed on the flat side with the risk, TENOTEN KID is inscribed on the other flat side.
Release form
lozenges. On 20 tablets in a blister strip packaging from a film of polyvinyl chloride and aluminum foil.
1, 2 or 5 blister packs along with instructions for medical use are placed in a pack of cardboard.
packaging 40 pcs
Pharmacological action
Pharmacotherapeutic group
anxiolytics, nootropics.
ATX codes
N05BX, N06BX.
Pharmacological action
The drug has a calming, anti-anxiety (anxiolytic) effect, without causing unwanted hypnogenic and muscle relaxant effects. Improves the tolerance of psycho-emotional stress. It has a stress-protective, nootropic, antiamnestic, antihypoxic, neuroprotective, antiasthenic, antidepressant effect.
In conditions of intoxication, hypoxia, in conditions after acute cerebrovascular accident, it has a neuroprotective effect, limits the damage zone, normalizes the processes of learning and memory in the central nervous system (CNS).
Inhibits lipid peroxidation.
The active form of the active substance is the active form with a content of not more than 10-16 ng / g of the active substance
Modifies the functional activity of the S-100 protein, which combines synaptic (informational) and metabolic processes in the brain. By providing a GABA-mimetic and neurotrophic effect, it increases the activity of stress-limiting systems and helps to restore the processes of neuronal plasticity.
Indications
Neurotic and neurosis-like disorders accompanied by increased irritability, irritability, anxiety, impaired behavior and attention, autonomic disorders.
Attention Deficit Hyperactivity Disorder.
Contraindications
Increased individual sensitivity to the components of the drug, children under 3 years of age.
Use during pregnancy and lactation
The safety of the drug Tenoten for children in pregnant women and during lactation has not been studied. If necessary, the risk / benefit ratio should be considered.
Composition
1 lozenge tablet contains: active substance: antibodies to the brain-specific protein S-100 affinity purified – 0.003 g *,
excipients: lactose, microcrystalline cellulose, magnesium stearate, srdlactose * is applied in the form of water alcohol mixture with a content of not more than 10 16 ng / g of the active form of the active substance
Dosage and Administration
Inside. At one time – 1 – 2 tablets (keep in mouth until completely dissolved – not during meals). If necessary, the tablet can be dissolved in a small amount of boiled water at room temperature.
Neurotic and neurosis-like disorders. Take 1 tablet from 1 to 3 times a day, the course of treatment is 1-3 months. If necessary, the course of treatment can be extended up to 6 months or repeated after 1 – 2 months.
Attention Deficit Hyperactivity Disorder. Take 2 tablets 2 times a day, the course of treatment is 1-3 months.
In the absence of persistent improvement within 3-4 weeks after the start of treatment, you should consult a doctor.
Side effects
Possible reactions of increased individual sensitivity to the components of the drug.
Drug Interaction
Incompatibilities with other drugs have not yet been reported.
Overdose
In the event of an accidental overdose, dyspepsia may occur due to the excipients included in the preparation.
Storage conditions
At a temperature not exceeding 25 ° C.
Keep out of the reach of children.
During the period of use of the drug, store blister packs in a cardboard box provided by the manufacturer.
Expiration
3 years.
Deystvuyuschee substances
Homeopatycheskyy composition
dosage form
dosage form
tablets
Materia Medica Holding, Russia
